SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 42 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $492,575 | +83.8% | 279,000 | +75.5% | 0.00% | – |
| Q2 2023 | $268,049 | -8.7% | 159,000 | +4.6% | 0.00% | – |
| Q1 2023 | $293,650 | -70.6% | 152,000 | -71.6% | 0.00% | -100.0% |
| Q4 2022 | $999,380 | +19.4% | 535,000 | +6.6% | 0.00% | 0.0% |
| Q3 2022 | $837,000 | +8.4% | 502,000 | -18.5% | 0.00% | 0.0% |
| Q2 2022 | $772,000 | +517.6% | 616,000 | +548.4% | 0.00% | – |
| Q1 2022 | $125,000 | -82.4% | 95,000 | -82.4% | 0.00% | – |
| Q2 2021 | $712,000 | +1680.0% | 540,000 | +1641.9% | 0.00% | – |
| Q1 2021 | $40,000 | +60.0% | 31,000 | +210.0% | 0.00% | – |
| Q4 2020 | $25,000 | -95.3% | 10,000 | -95.8% | 0.00% | – |
| Q2 2019 | $532,000 | -90.5% | 239,000 | -92.3% | 0.00% | -100.0% |
| Q1 2019 | $5,592,000 | – | 3,099,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DeepCurrents Investment Group LLC | 92,999,000 | $138,298,000 | 4.13% |
| WOLVERINE ASSET MANAGEMENT LLC | 84,505,000 | $125,210,000 | 1.08% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 20,000,000 | $29,789,000 | 0.79% |
| Verition Fund Management LLC | 27,047,000 | $40,063,000 | 0.35% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 7,970,000 | $11,789,000 | 0.22% |
| Baker Brothers Advisors | 29,174,000 | $43,167,000 | 0.19% |
| Calamos Advisors LLC | 23,631,000 | $35,035,000 | 0.15% |
| RWC Asset Management LLP | 2,900,000 | $4,300,000 | 0.13% |
| Aequim Alternative Investments LP | 1,957,000 | $2,899,000 | 0.11% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,148,000 | $4,666,000 | 0.10% |